Clinical Trials
10 trialsNCT03206060 2026-04-24
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT03604198 2026-04-21
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
Phase 2 Active not recruiting
NCT04401267 2025-11-03
Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma
St. Jude Children's Research Hospital
Phase 2 Completed
NCT01761877 2023-02-10
NSAID Effects on Clinical and Imaging Breast Biomarkers
Stony Brook University
Phase 2 Completed
NCT01392352 2020-02-13
HYPAZ
Cambridge University Hospitals NHS Foundation Trust
Phase 2 Terminated
NCT02804750 2019-10-15
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Corcept Therapeutics
Phase 2 Completed
NCT01234922 2018-08-28
Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
Wake Forest University Health Sciences
Phase 2 Terminated
NCT02001051 2018-06-14
Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT02222480 2016-07-01
A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide
Boryung Pharmaceutical Co., Ltd
Phase 2 Completed
NCT00264004 2012-08-29
Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours
AstraZeneca
Phase 2 Completed